Detection of ROS in Dormant Breast Cancer Cell
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Dormant metastatic breast cancer cells in the lung activate mitochondrial reactive oxygen species (ROS) production. This triggers an antioxidant response, protecting cancer cells from chemotherapy and highlighting novel in vivo detection methods.
Area Of Science
- Biochemistry
- Cell Biology
- Oncology
Background
- Reactive oxygen species (ROS) are crucial signaling molecules involved in cell homeostasis and disease.
- Oxidative stress and physiological ROS production play dual roles in cellular processes.
- Dormant metastatic breast cancer cells in the lung microenvironment present unique challenges for treatment.
Purpose Of The Study
- To investigate the role of mitochondrial ROS in dormant metastatic breast cancer cells.
- To understand the mechanism by which metastatic cells evade chemotherapy.
- To develop a method for detecting ROS in vivo in metastatic lung tissue.
Main Methods
- Analysis of mitochondrial ROS production in metastatic breast cancer cells.
- Investigating the influence of extracellular matrix (ECM) mechanical properties on ROS.
- Utilizing the NRF2 transcription factor in antioxidant response.
- Developing a protocol for detecting 4-hydroxy-2-noneal (4HNE) adducts in fixed mouse lung tissue.
Main Results
- Metastatic breast cancer cells in the lung activate mitochondrial ROS production in response to ECM stiffness.
- This ROS production triggers an NRF2-mediated antioxidant response.
- The antioxidant response confers resistance to cisplatin chemotherapy in dormant cells.
- A protocol was established for in vivo ROS detection via 4HNE adducts in lung tissue.
Conclusions
- Mechanical cues in the lung microenvironment regulate ROS production in dormant breast cancer metastases.
- Targeting ROS or NRF2 pathways may overcome chemotherapy resistance in metastatic breast cancer.
- The developed protocol enables in vivo assessment of ROS in metastatic lung tissue, advancing diagnostic capabilities.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.